62 related articles for article (PubMed ID: 22735362)
1. Renal effects of high-dose celecoxib in elderly men with stage D2 prostate carcinoma.
Benson P; Yudd M; Sims D; Chang V; Srinivas S; Kasimis B
Clin Nephrol; 2012 Nov; 78(5):376-81. PubMed ID: 22735362
[TBL] [Abstract][Full Text] [Related]
2. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects.
Dilger K; Herrlinger C; Peters J; Seyberth HW; Schweer H; Klotz U
J Clin Pharmacol; 2002 Sep; 42(9):985-94. PubMed ID: 12211224
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
[TBL] [Abstract][Full Text] [Related]
5. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
6. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
Raml A; Schmekal B; Grafinger P; Biesenbach G
Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.
Herrera FG; Chan P; Doll C; Milosevic M; Oza A; Syed A; Pintilie M; Levin W; Manchul L; Fyles A
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):97-103. PubMed ID: 17056201
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
Pruthi RS; Derksen JE; Moore D; Carson CC; Grigson G; Watkins C; Wallen E
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2172-7. PubMed ID: 16609031
[TBL] [Abstract][Full Text] [Related]
11. "Quadruple whammy"- a preventable newly described syndrome of post-operative AKI in CKD II and CKD III patients on combination "Triple whammy" medications: a Mayo Clinic Health System, Eau Claire, Wisconsin experience.
Onuigbo MA; Agbasi N
Niger J Clin Pract; 2014; 17(5):649-54. PubMed ID: 25244280
[TBL] [Abstract][Full Text] [Related]
12. The impact of acute kidney injury on short-term survival in an Eastern European population with stroke.
Covic A; Schiller A; Mardare NG; Petrica L; Petrica M; Mihaescu A; Posta N
Nephrol Dial Transplant; 2008 Jul; 23(7):2228-34. PubMed ID: 17989102
[TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
Cheung R; Krishnaswami S; Kowalski K
Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice.
Wang W; Zolty E; Falk S; Summer S; Stearman R; Geraci M; Schrier R
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1131-6. PubMed ID: 17652370
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
17. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
18. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
[TBL] [Abstract][Full Text] [Related]
19. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.
Maioli M; Toso A; Leoncini M; Gallopin M; Musilli N; Bellandi F
Circulation; 2012 Jun; 125(25):3099-107. PubMed ID: 22592896
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib does not alter cardiovascular and renal function during dietary salt loading.
Wenner MM; Edwards DG; Ray CA; Rose WC; Gardner TJ; Stillabower M; Farquhar WB
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):543-9. PubMed ID: 21631568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
